On July 11, 2024, Indegene announced via a stock exchange filing that it has partnered with Microsoft to advance GenAI services for global life sciences companies. They plan to develop specialised tools for medical and technology sectors to enhance AI services across commercial, medical, regulatory, and clinical functions. Tarun Mathur, CTO of Indegene, said, “GenAI …